James Bearden to Excitatory Amino Acid Antagonists
This is a "connection" page, showing publications James Bearden has written about Excitatory Amino Acid Antagonists.
Connection Strength
0.022
-
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011 Jun; 19(6):833-41.
Score: 0.022
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.